Recently, it has been shown that, in vascular tissue where endothelial dysfunction is present and NO bioavailability is decreased, VASP phosphorylation at Ser239 was strikingly reduced (Oelze et al., 2000; Mülsch et al., 2001). This evidence concerns the gene VASP and endothelial dysfunction.